Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Yapeng Zhang

Yapeng Zhang

Scientific Informatics Expert, Professional Services

About the author: With a PhD in Medicinal Chemistry, I have over 10 years of experience in the drug R&D area. I am skilled in medicinal chemistry, informatics and data science, along with customer engagement skill sets. I now work as a Scientific Informatics Expert in the Professional Service group at Elsevier and am taking responsibility on customer engagement and data science projects for deeply mining scientific impacts from big data on the drug R&D process.

Posts by Yapeng Zhang

Modulators, Biomarkers and Potential Treatments for COVID-19

Posted on May 14th, 2020 in COVID-19

With the trend of open science, people are becoming more receptive to the idea of sharing data and using what is already accessible. Particularly for researchers, there is so much data available that can answer questions and develop hypotheses and strategies that could save effort, time and money. This is mainly important in cases where rapid discoveries are required, such as in the case of the current COVID-19 outbreak.